<DOC>
	<DOCNO>NCT01280175</DOCNO>
	<brief_summary>The purpose study evaluate systemic exposure BDP , metabolite beclomethasone 17-monopropionate ( B17MP ) formoterol inhalation BDP/Formoterol 100/6 µg pMDI combination ( CHF1535 ) use standard actuator charcoal block technique use Spacer ( AeroChamber Plus , Trudell ) comparison inhalation use standard actuator</brief_summary>
	<brief_title>Foster With Without Charcoal Block Aerochamber Plus</brief_title>
	<detailed_description />
	<mesh_term>Charcoal</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Sex : male 18≤age≤45 year old BMI : 18≤BMI≤28 kg/m2 Nonsmokers Vital sign : SBP 100139 mmHg , DBP 5089 , HR 5090 bpm , measure 5 min rest sit position Full comprehension : ability use correctly pMDI preparation ; ability comprehend full nature purpose study , include possible risk side effect ; ability cooperate Investigator comply requirement entire study Informed Consent : sign write informed consent prior inclusion study . ECG ( 12 lead ) : clinically relevant abnormality and/or QTc &gt; 450 msec ; Physical finding : clinically relevant abnormal physical finding , could interfere objective study ; particular abnormality lung functionality : FEV1 &lt; 80 % predict value accord European Respiratory Society base upon Quanjer et al . ( 25 ) Laboratory analysis : clinically relevant abnormal laboratory value indicative physical illness ; particular positive HIV1 HIV2 serology and/or positive hepatitis serology indicate acute chronic hepatitis B C Allergy : ascertain presumptive hypersensitivity active principle and/or formulation ' ingredient ; history anaphylaxis drug allergic reaction general , Investigator considers may affect outcome study Diseases : relevant history renal , hepatic , gastrointestinal , cardiovascular , respiratory , skin , haematological , endocrine neurological disease , may interfere aim study Medications : medication , include OTC , 2 week start study . Any known enzyme induce drug enzyme inhibitor must stop least 2 month study start Investigative drug trial : participation evaluation drug within 3 month prior screen Blood donation : blood donation 3 month prior study Drug , alcohol , caffeine , tobacco : history drug , alcohol [ &gt; 2 drinks/day , define accord USDA Dietary Guidelines 2005 ( 26 ) ] , caffeine ( &gt; 5 cup coffee/tea/day ) abuse smoke Abnormal diet ( &lt; 1600 &gt; 3500 kcal/day ) substantial change eat habit within past 4 week .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>BDP</keyword>
	<keyword>Formoterol</keyword>
	<keyword>pMDI</keyword>
	<keyword>Aerochamber Plus</keyword>
	<keyword>Charcoal</keyword>
</DOC>